Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > FULLY DILUTED 185 MILLION SHARES
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by deminimison Jan 21, 2018 2:52pm
333 Views
Post# 27404034

RE:RE:FULLY DILUTED 185 MILLION SHARES

RE:RE:FULLY DILUTED 185 MILLION SHARESConsidering their book value is $215M, a $385M market cap is a tremendous value. This means the market is only assigning a value of $170M for intangibles such as future growth, brand and other IP such as pharmaceutical product development and managment. Compare that to every other company in the sector and this feels like stealing. Start the car! Start the car! https://youtu.be/NlWCLw75XnE

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities